Top Glove Corporation Bhd. (TGLVY)
USD 1.06
(0.0%)
USD 1.06
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 302.07 Million MYR | 1945.39% |
| 2022 | -16.36 Million MYR | 95.83% |
| 2021 | -392.82 Million MYR | 39.87% |
| 2020 | -653.29 Million MYR | -128.89% |
| 2019 | 2.26 Billion MYR | 10.39% |
| 2018 | 2.04 Billion MYR | 1402.35% |
| 2017 | 136.32 Million MYR | -22.25% |
| 2016 | 175.33 Million MYR | -64.19% |
| 2015 | 489.56 Million MYR | 14886.05% |
| 2014 | -3.31 Million MYR | 94.88% |
| 2013 | -64.72 Million MYR | 60.6% |
| 2012 | -164.27 Million MYR | -12.71% |
| 2011 | -145.75 Million MYR | 43.8% |
| 2010 | -259.36 Million MYR | -56.89% |
| 2009 | -165.31 Million MYR | -352.61% |
| 2008 | 65.44 Million MYR | 145.94% |
| 2007 | 26.6 Million MYR | -87.53% |
| 2006 | 213.45 Million MYR | 65.39% |
| 2005 | 129.06 Million MYR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 1.27 Billion MYR | -66.91% |
| 2024 Q1 | 287.11 Million MYR | -4.95% |
| 2024 Q2 | 1.48 Billion MYR | 7.6% |
| 2023 Q2 | 103.83 Million MYR | 2424.9% |
| 2023 Q1 | -4.46 Million MYR | 72.72% |
| 2023 Q3 | 263.18 Million MYR | 153.47% |
| 2023 FY | 302.07 Million MYR | 1945.39% |
| 2023 Q4 | 302.07 Million MYR | 14.78% |
| 2022 Q3 | -28.39 Million MYR | 75.0% |
| 2022 FY | -16.36 Million MYR | 95.83% |
| 2022 Q1 | -433.98 Million MYR | -10.48% |
| 2022 Q4 | -16.36 Million MYR | 42.34% |
| 2022 Q2 | -113.54 Million MYR | 73.84% |
| 2021 Q2 | -1.86 Billion MYR | -144.15% |
| 2021 Q4 | -392.82 Million MYR | 23.38% |
| 2021 FY | -392.82 Million MYR | 39.87% |
| 2021 Q3 | -512.71 Million MYR | 72.56% |
| 2021 Q1 | -765.19 Million MYR | -17.13% |
| 2020 FY | -653.29 Million MYR | -128.89% |
| 2020 Q1 | 2.34 Billion MYR | 3.88% |
| 2020 Q3 | 1.17 Billion MYR | -21.37% |
| 2020 Q4 | -653.29 Million MYR | -155.72% |
| 2020 Q2 | 1.49 Billion MYR | -36.51% |
| 2019 Q4 | 2.26 Billion MYR | 7.38% |
| 2019 FY | 2.26 Billion MYR | 10.39% |
| 2019 Q1 | 2.05 Billion MYR | 0.43% |
| 2019 Q3 | 2.1 Billion MYR | 5.28% |
| 2019 Q2 | 2 Billion MYR | -2.76% |
| 2018 Q1 | 162.31 Million MYR | 19.06% |
| 2018 Q4 | 2.04 Billion MYR | 9.06% |
| 2018 Q3 | 1.87 Billion MYR | 369.14% |
| 2018 FY | 2.04 Billion MYR | 1402.35% |
| 2018 Q2 | 400.29 Million MYR | 146.61% |
| 2017 Q2 | 243.84 Million MYR | -10.37% |
| 2017 Q1 | 272.06 Million MYR | 55.17% |
| 2017 Q3 | 131.77 Million MYR | -45.96% |
| 2017 FY | 136.32 Million MYR | -22.25% |
| 2017 Q4 | 136.32 Million MYR | 3.45% |
| 2016 FY | 175.33 Million MYR | -64.19% |
| 2016 Q4 | 175.33 Million MYR | -32.63% |
| 2016 Q3 | 260.24 Million MYR | 748.06% |
| 2016 Q2 | 30.68 Million MYR | 3.86% |
| 2016 Q1 | 29.54 Million MYR | -93.96% |
| 2015 Q3 | 231 Million MYR | -25.88% |
| 2015 FY | 489.56 Million MYR | 14886.05% |
| 2015 Q1 | 235.14 Million MYR | 7202.02% |
| 2015 Q2 | 311.64 Million MYR | 32.53% |
| 2015 Q4 | 489.56 Million MYR | 111.93% |
| 2014 Q1 | -58.54 Million MYR | 9.54% |
| 2014 Q3 | -155.04 Million MYR | -425.63% |
| 2014 Q2 | 47.61 Million MYR | 181.33% |
| 2014 FY | -3.31 Million MYR | 94.88% |
| 2014 Q4 | -3.31 Million MYR | 97.86% |
| 2013 Q4 | -64.72 Million MYR | 20.58% |
| 2013 Q2 | -131.53 Million MYR | 33.25% |
| 2013 Q1 | -197.04 Million MYR | -19.95% |
| 2013 FY | -64.72 Million MYR | 60.6% |
| 2013 Q3 | -81.49 Million MYR | 38.04% |
| 2012 FY | -164.27 Million MYR | -12.71% |
| 2012 Q3 | -219.53 Million MYR | -22.5% |
| 2012 Q2 | -179.21 Million MYR | 0.0% |
| 2012 Q4 | -164.27 Million MYR | 25.17% |
| 2011 Q4 | -145.75 Million MYR | 0.0% |
| 2011 FY | -145.75 Million MYR | 43.8% |
| 2010 FY | -259.36 Million MYR | -56.89% |
| 2009 FY | -165.31 Million MYR | -352.61% |
| 2008 FY | 65.44 Million MYR | 145.94% |
| 2007 FY | 26.6 Million MYR | -87.53% |
| 2006 FY | 213.45 Million MYR | 65.39% |
| 2005 FY | 129.06 Million MYR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -62880.083% |
| Ansell Limited | -54.99 Million USD | 649.253% |
| Ansell Limited | -55.1 Million USD | 648.225% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 927.75% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 287508.422% |
| Psykey, Inc. | 634.59 Thousand USD | -47500.903% |
| ConvaTec Group Plc | 1.2 Billion USD | 74.84% |
| ConvaTec Group Plc | 1.2 Billion USD | 74.875% |
| Encision Inc. | 1.29 Million USD | -23303.861% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -12983.977% |
| Innovative MedTech Inc. | 1.76 Million USD | -17017.121% |
| LifePoint, Inc. | -3.26 Million USD | 9354.597% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | -6059.478% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | -13871.878% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 697661.426% |
| Reflect Scientific, Inc. | -1.03 Million USD | 29277.046% |
| SmileDirectClub, Inc. | 778.67 Million USD | 61.207% |
| Sector 10, Inc. | 163 Thousand USD | -185220.245% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 172.343% |
| SheerVision, Inc. | 57.34 Thousand USD | -526625.837% |
| United Health Products, Inc. | 660.56 Thousand USD | -45629.061% |
| Vasamed, Inc. | 22.12 Thousand USD | -1365382.325% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | -11380.306% |
| Yubo International Biotech Limited | 772.27 Thousand USD | -39014.362% |